Source: Redox Biology. Unidades: FMRP, FORP
Subjects: HIPERTENSÃO, ÓXIDO NÍTRICO, METALOPROTEINASES, FÁRMACOS (SISTEMA CARDIOVASCULAR)
ABNT
GUIMARÃES, Danielle A. et al. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension. Redox Biology, v. 6, p. 386-395, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.redox.2015.08.017. Acesso em: 21 maio 2024.APA
Guimarães, D. A., Rizzi, E., Ceron, C. S., Martins-Oliveira, A., Gerlach, R. F., Shiva, S., & Tanus-Santos, J. E. (2015). Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension. Redox Biology, 6, 386-395. doi:10.1016/j.redox.2015.08.017NLM
Guimarães DA, Rizzi E, Ceron CS, Martins-Oliveira A, Gerlach RF, Shiva S, Tanus-Santos JE. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension [Internet]. Redox Biology. 2015 ; 6 386-395.[citado 2024 maio 21 ] Available from: https://doi.org/10.1016/j.redox.2015.08.017Vancouver
Guimarães DA, Rizzi E, Ceron CS, Martins-Oliveira A, Gerlach RF, Shiva S, Tanus-Santos JE. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension [Internet]. Redox Biology. 2015 ; 6 386-395.[citado 2024 maio 21 ] Available from: https://doi.org/10.1016/j.redox.2015.08.017